NASDAQ:LABT

Lakewood-amedex Biotherapeutics . Common Stock Stock Insider Trading

*Your capital is at risk

$2.35

+0.130 (+5.86%)

At Close: Aug 10, 2026

Lakewood-amedex Biotherapeutics . Common Stock Stock Insider Power

Based on the 18 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 862.67K and sold 0 LABT shares in the last 18 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 18 transactions)	100.00
● Buy	862.67K shares
● Sell	0 shares
100% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Apr 24, 2026 Buy	Warrant to acquire Common Stock A-Award	Tucker Joseph Edward Director	Director	33 784 Value: $337.8K
Apr 24, 2026 Buy	Common Stock; $0.0001 par value	Tucker Joseph Edward Director	Director	0 Value: $0
Apr 17, 2026 Buy	Common Stock; $0.0001 par value	Deroma Leonard James Director	Director	0 Value: $0
Apr 17, 2026 Buy	Common Stock; $0.0001 par value	Balzer Thomas Chief Medical Officer	Officer	0 Value: $0
Apr 17, 2026 Buy	Common Stock; $0.0001 par value	Cooper Kelvin Chief Executive Officer	CEO / President	0 Value: $0
Apr 17, 2026 Buy	Common Stock; $0.0001 par value	Ceccacci Peter Chief Financial Officer	C-Suite Officer	0 Value: $0
Nov 01, 2025 Buy	Option (right to buy)	Cooper Kelvin Chief Executive Officer	CEO / President	13 514 Value: $37.6K
Jul 02, 2025 Buy	Option (right to buy)	Balzer Thomas Chief Medical Officer	Officer	168 919 Value: $390.2K
Jul 02, 2025 Buy	Option (right to buy)	Cooper Kelvin Chief Executive Officer	CEO / President	202 703 Value: $468.2K
Jul 02, 2025 Buy	Option (right to buy)	Ceccacci Peter Chief Financial Officer	C-Suite Officer	202 703 Value: $468.2K
Mar 14, 2025 Buy	Option (right to buy)	Balzer Thomas Chief Medical Officer	Officer	46 115 Value: $98.2K
Mar 14, 2025 Buy	Option (right to buy)	Ceccacci Peter Chief Financial Officer	C-Suite Officer	29 561 Value: $63.0K
Aug 01, 2024 Buy	Option (right to buy)	Cooper Kelvin Chief Executive Officer	CEO / President	72 467 Value: $154.4K
Jul 12, 2022 Buy	Warrants	Deroma Leonard James Director	Director	8 446 Value: $18.0K
Mar 01, 2022 Buy	Option (right to buy)	Ceccacci Peter Chief Financial Officer	C-Suite Officer	33 784 Value: $93.9K
Jul 12, 2021 Buy	Warrants	Deroma Leonard James Director	Director	8 446 Value: $23.5K
Jul 12, 2020 Buy	Warrants	Deroma Leonard James Director	Director	8 446 Value: $20.0K
Jan 12, 2018 Buy	Warrants	Deroma Leonard James Director	Director	33 784 Value: $200.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks